Biomarkers discovered that predict which patients will not respond well to chemotherapy

Scientists at the Spanish National Cancer Research Centre (CNIO), in collaboration with the University of Cambridge, have discovered biomarkers that predict which patients will not respond well to chemotherapy using data from 840 patients with breast, prostate, ovarian, and sarcoma cancer.